These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 1825266)

  • 41. [Effects of administration of a single dose of iprafen (l puff) compared with those of a single dose of ipratropium bromide (40 mcg.) and of fenoterol (100 mcg.)].
    Marcatili S; Maselli R
    Arch Monaldi; 1984; 39(1-2):37-44. PubMed ID: 6241821
    [No Abstract]   [Full Text] [Related]  

  • 42. The duration of action of the combination of fenoterol hydrobromide and ipratropium bromide in protecting against asthma provoked by hyperpnea.
    Smith CM; Anderson SD; Seale JP
    Chest; 1988 Oct; 94(4):709-17. PubMed ID: 2971514
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Long-term effect of ipratropium bromide and fenoterol on the bronchial hyperresponsiveness to histamine in children with asthma.
    Raes M; Mulder P; Kerrebijn KF
    J Allergy Clin Immunol; 1989 Dec; 84(6 Pt 1):874-9. PubMed ID: 2532229
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Long-term therapy of bronchial asthma with ingacort].
    Leshchenko IV; Kuznetsova EI
    Ter Arkh; 1997; 69(12):52-4. PubMed ID: 9503537
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Preliminary data from phase II studies with Respimat, a propellant-free soft mist inhaler.
    Pavia D; Moonen D
    J Aerosol Med; 1999; 12 Suppl 1():S33-9. PubMed ID: 10623340
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A comparison of the effects of anticholinergic and beta 2-agonist and combination therapy on respiratory impedance in COPD.
    Wesseling G; Mostert R; Wouters EF
    Chest; 1992 Jan; 101(1):166-73. PubMed ID: 1530836
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Optimal dose of fenoterol by metered-dose inhaler in asthmatic adults.
    Conrad SA; Light RW; George RB
    Chest; 1986 Mar; 89(3):394-7. PubMed ID: 3512188
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Use of a nebulizer as a new method of drug administration in treating dyspnea attacks in patients with bronchial asthma].
    Sidorova LD; German EIu; Logvinenko AS; Korolenko LP
    Ter Arkh; 1999; 71(3):17-8. PubMed ID: 10234756
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Evaluation of the efficacy of the combination of fenoterol and ipratropium bromide (Duovent) in asthmatic subjects.
    Bariffi F; Gaicomelli P; Sanduzzi A; De Masi AL
    Respiration; 1986; 50 Suppl 2():155-9. PubMed ID: 2951796
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [The experience with berodual inhalation in emergency treatment of bronchial asthma].
    Leshchenko IV; Bushuev AV; Naumenko AV
    Klin Med (Mosk); 1997; 75(12):55-6. PubMed ID: 9503816
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Dose-effect relationship of the beta-agonists fenoterol and salbutamol in patients with asthma.
    Newhouse MT; Dolovich MB; Kazim F
    Chest; 1994 Jun; 105(6):1738-42. PubMed ID: 8205869
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [The effect of inhaling pirenzepine--selective M1 receptor antagonist and ipratropium bromide on lung ventilation in patients with bronchial asthma].
    Krasnowska M; Jankowska R; Jagiełło E
    Pneumonol Alergol Pol; 1994; 62(11-12):609-14. PubMed ID: 7719260
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [A new inhalation system for bronchodilatation. Study of the acceptance of the Ingelheim M inhaler in chronic obstructive respiratory tract diseases].
    Mütterlein R; Schmidt G; Fleischer W; Freund E
    Fortschr Med; 1990 Apr; 108(11):225-8. PubMed ID: 2141590
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Reversibility tests in chronic obstructive airways disease: their predictive value with reference to benefit from domiciliary nebuliser therapy.
    Teale C; Morrison JF; Jones PC; Muers MF
    Respir Med; 1991 Jul; 85(4):281-4. PubMed ID: 1835110
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Clinical efficacy and safety of the combination of ipratropium bromide and fenoterol inhaled via the Respimat Soft Mist inhaler for relief of airflow obstruction.
    Vincken W
    Expert Rev Respir Med; 2008 Feb; 2(1):11-26. PubMed ID: 20477218
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Bronchodilating effects of Berotec, Berodual and Atrovent in asthmatics.
    Salát D; Palecek D; Salátová V
    Acta Physiol Hung; 1987; 70(2-3):219-21. PubMed ID: 2963483
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Clinical and cost effectiveness of nebulizer therapy in emergency care for acute bronchial asthma].
    Leshchenko IV; Ulybin IB; Bushuev AV
    Ter Arkh; 2000; 72(8):13-6. PubMed ID: 11019418
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Use of nebulizer in berodual treatment of patients with chronic obstructive bronchitis in exacerbation].
    Shmelev EI; Khmel'kova NG; Abubikirov AF
    Ter Arkh; 2000; 72(3):26-8. PubMed ID: 10776649
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Dose-response relationship: fenoterol, ipratropium bromide and their combination.
    Ciappi G; Magnini P; Valente S; Toscano L; Corbo GM; Culla G; Patalano F
    Respiration; 1986; 50 Suppl 2():140-3. PubMed ID: 2951792
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Use of ipratropium bromide by inhalation in the treatment of acute asthma in children. Clinical experience].
    Beck R
    Arch Pediatr; 1995; 2 Suppl 2():145S-148S. PubMed ID: 7633554
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.